ANEB

Anebulo Pharmaceuticals, Inc. [ANEB] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

ANEB Stock Summary

Top 10 Correlated ETFs

ANEB

Top 10 Correlated Stocks

ANEB

In the News

ANEB Financial details

Company Rating
-
Market Cap
75.34M
Income
-10.43M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-5.37
Forward P/E
-
PEG
-1.25
P/S
-
P/B
7.45
P/C
-
P/FCF
-5.98
Quick Ratio
11.89
Current Ratio
12.63
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.41
EPS next Y
-
EPS next Q
-
EPS this Y
62.07%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
13.64%
-
-
-
-
SMA20
-
SMA50
-50%
SMA100
-50%
Inst Own
-
Inst Trans
-
ROA
-128%
ROE
-97%
ROC
-1.41%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.62-4.05
52W High
-70.75%
52W Low
+17%
RSI
40
Rel Volume
2.41
Avg Volume
5.69K
Volume
13.69K
Perf Week
-24.52%
Perf Month
-7.14%
Perf Quarter
-37.43%
Perf Half Y
-42.93%
-
-
-
-
Beta
-1.005
-
-
Volatility
0.07%, 0.26%
Prev Close
-10%
Price
1.17
Change
-11.7%

Something similar

Top by Market Cap
BRH.DE
AAPL
FB2A.DE
VOO
META
Top Correlated ETFs
CRAK
EMIF
GUNR
FBZ
FLN
Top Correlated Stocks
GTN
PTL-R.BK
A1OS.DE
002731.SZ
0SE5.L
Similar Market Cap
ESO.L
PARRO.PA
THCPU
ITAQU
EEP.PA

Company Profile

Healthcare Biotechnology
  • Volume Average 5.69K
  • Market Capitalization 75.34M
  • Employee 2
  • CEO Mr. Richard Anthony Cunningham
  • Headquarters Lakeway,TX,US
  • IPO Date 2021-05-07
  • Website https://www.anebulo.com

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.